Sirolimus in Treating Patients With Advanced Pancreatic Cancer RATIONALE: Sirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying how well sirolimus works in treati...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy RATIONALE: Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This phase II trial is st...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer Targeting tumor stroma is emerging as a strategic approach for pancreatic cancer treatment. Actually, one of the most interesting characteristics of pancreatic cancer is the dense fibrotic...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Safety/Tolerability Study of AV-412 in Subjects With Refractory or Relapsed Solid Tumor Malignancies AV-412 is a new oral therapy developed to inhibit the growth of solid tumors in patients who have not responded to standard therapy or surgical interventions, or who have experienced relap...

• Pays Argentina, United States
• Organes Aucun
• Spécialités Aucune

Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors RATIONALE: Sirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is studying the side effects and best dose of s...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune